Epigenetic Priming
Top View
- AML) Patient’S Response to First Line Therapy? • What Are the Epigenetic Mechanism Regulating OCTN1 Expression?
- Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant
- OKI-179, a 1St in Class, Orally Administered HDAC Inhibitor with a Romidepsin-Like Profile
- A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer Amit M
- An Epigenetic Priming Mechanism Mediated by Nutrient Sensing Regulates
- Epigenetic Priming Drives Aberrant Gene Expression Linked to Cocaine Relapse
- Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable
- From Drug Combinations to Epigenetic Editing
- A Multicenter, Randomized Study of Decitabine As Epigenetic
- Blood Lipids Influence DNA Methylation in Circulating Cells Koen F
- Recent Clinical Update of Acute Myeloid Leukemia
- Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges
- Chromatin Modifiers and Remodellers: Regulators of Cellular Differentiation
- A Randomized Phase 2 Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer
- Epigenetic Mechanisms in Lung Cancer
- Epigenetic Therapy in Lung Cancer
- A Phase 1 Study of Azacitidine with High-Dose Cytarabine and Mitoxantrone in High-Risk Acute Myeloid Leukemia
- Combinatorial Epigenetic and Immunotherapy in Breast Cancer Management: a Literature Review